Literature DB >> 16996161

On the influence of vector design on antibody phage display.

Glenn Soltes1, Michael Hust, Kitty K Y Ng, Aasthaa Bansal, Johnathan Field, Donald I H Stewart, Stefan Dübel, Sanghoon Cha, Erik J Wiersma.   

Abstract

Phage display technology is an established technology particularly useful for the generation of monoclonal antibodies (mAbs). The isolation of phagemid-encoded mAb fragments depends on several features of a phage preparation. The aims of this study were to optimize phage display vectors, and to ascertain if different virion features can be optimized independently of each other. Comparisons were made between phagemid virions assembled by g3p-deficient helper phage, Hyperphage, Ex-phage or Phaberge, or corresponding g3p-sufficient helper phage, M13K07. All g3p-deficient helper phage provided a similar level of antibody display, significantly higher than that of M13K07. Hyperphage packaged virions at least 100-fold more efficiently than did Ex-phage or Phaberge. Phaberge's packaging efficiency improved by using a SupE strain. Different phagemids were also compared. Removal of a 56 base pair fragment from the promoter region resulted in increased display level and increased virion production. This critical fragment encodes a lacZ'-like peptide and is also present in other commonly used phagemids. Increasing display level did not show statistical correlation with phage production, phage infectivity or bacterial growth rate. However, phage production was positively correlated to phage infectivity. In summary, this study demonstrates simultaneously optimization of multiple and independent features of importance for phage selection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16996161      PMCID: PMC1866265          DOI: 10.1016/j.jbiotec.2006.08.015

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  34 in total

1.  A new helper phage and phagemid vector system improves viral display of antibody Fab fragments and avoids propagation of insert-less virions.

Authors:  Glenn Soltes; Heather Barker; Kristine Marmai; Elaine Pun; Amy Yuen; Erik J Wiersma
Journal:  J Immunol Methods       Date:  2003-03-01       Impact factor: 2.303

2.  Mating antibody phage display with proteomics.

Authors:  Michael Hust; Stefan Dübel
Journal:  Trends Biotechnol       Date:  2004-01       Impact factor: 19.536

Review 3.  Antibodies from phage antibody libraries.

Authors:  Andrew R M Bradbury; James D Marks
Journal:  J Immunol Methods       Date:  2004-07       Impact factor: 2.303

4.  Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains.

Authors:  H R Hoogenboom; A D Griffiths; K S Johnson; D J Chiswell; P Hudson; G Winter
Journal:  Nucleic Acids Res       Date:  1991-08-11       Impact factor: 16.971

5.  Screening of phage antibody libraries.

Authors:  J L Harrison; S C Williams; G Winter; A Nissim
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

6.  Inclusion of an upstream transcriptional terminator in phage display vectors abolishes background expression of toxic fusions with coat protein g3p.

Authors:  A Krebber; J Burmester; A Plückthun
Journal:  Gene       Date:  1996-10-31       Impact factor: 3.688

Review 7.  Aspects of the growth and regulation of the filamentous phages.

Authors:  W Fulford; M Russel; P Model
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1986

8.  Phage display of a human antibody against Clostridium tetani toxin.

Authors:  G Esposito; E Scarselli; C Traboni
Journal:  Gene       Date:  1994-10-11       Impact factor: 3.688

9.  A phagemid vector using the E. coli phage shock promoter facilitates phage display of toxic proteins.

Authors:  J Beekwilder; J Rakonjac; M Jongsma; D Bosch
Journal:  Gene       Date:  1999-03-04       Impact factor: 3.688

10.  The remarkable flexibility of the human antibody repertoire; isolation of over one thousand different antibodies to a single protein, BLyS.

Authors:  Bryan M Edwards; Steven C Barash; Sarah H Main; Gil H Choi; Ralph Minter; Stephen Ullrich; Elizabeth Williams; Leila Du Fou; Jane Wilton; Vivian R Albert; Steve M Ruben; Tristan J Vaughan
Journal:  J Mol Biol       Date:  2003-11-14       Impact factor: 5.469

View more
  28 in total

Review 1.  Progress in phage display: evolution of the technique and its application.

Authors:  Tomaz Bratkovic
Journal:  Cell Mol Life Sci       Date:  2010-03       Impact factor: 9.261

Review 2.  Bacteriophage vehicles for phage display: biology, mechanism, and application.

Authors:  Walead Ebrahimizadeh; Masoumeh Rajabibazl
Journal:  Curr Microbiol       Date:  2014-03-18       Impact factor: 2.188

3.  Generation and characterization of protective antibodies to Marburg virus.

Authors:  Jeffrey W Froude; Thibaut Pelat; Sebastian Miethe; Samantha E Zak; Anna Z Wec; Kartik Chandran; Jennifer Mary Brannan; Russell R Bakken; Michael Hust; Philippe Thullier; John M Dye
Journal:  MAbs       Date:  2017-03-13       Impact factor: 5.857

4.  In vivo elimination of parental clones in general and site-directed mutagenesis.

Authors:  Erika G Holland; Felicity E Acca; Kristina M Belanger; Mary E Bylo; Brian K Kay; Michael P Weiner; Margaret M Kiss
Journal:  J Immunol Methods       Date:  2014-12-15       Impact factor: 2.303

5.  Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity.

Authors:  Thibaut Pelat; Michael Hust; Martha Hale; Marie-Paule Lefranc; Stefan Dübel; Philippe Thullier
Journal:  BMC Biotechnol       Date:  2009-06-30       Impact factor: 2.563

6.  High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation.

Authors:  Thibaut Pelat; Michael Hust; Emmanuelle Laffly; Florence Condemine; Chantal Bottex; Dominique Vidal; Marie-Paule Lefranc; Stefan Dübel; Philippe Thullier
Journal:  Antimicrob Agents Chemother       Date:  2007-05-21       Impact factor: 5.191

7.  DeltaPhage--a novel helper phage for high-valence pIX phagemid display.

Authors:  Nicolay R Nilssen; Terje Frigstad; Sylvie Pollmann; Norbert Roos; Bjarne Bogen; Inger Sandlie; Geir Å Løset
Journal:  Nucleic Acids Res       Date:  2012-04-26       Impact factor: 16.971

8.  Identification of immunogenic proteins and generation of antibodies against Salmonella Typhimurium using phage display.

Authors:  Torsten Meyer; Thomas Schirrmann; André Frenzel; Sebastian Miethe; Janin Stratmann-Selke; Gerald F Gerlach; Katrin Strutzberg-Minder; Stefan Dübel; Michael Hust
Journal:  BMC Biotechnol       Date:  2012-06-15       Impact factor: 2.563

9.  Suppression of p75 neurotrophin receptor surface expression with intrabodies influences Bcl-xL mRNA expression and neurite outgrowth in PC12 cells.

Authors:  Congcong Zhang; Saskia Helmsing; Marta Zagrebelsky; Thomas Schirrmann; Andrea L J Marschall; Manuela Schüngel; Martin Korte; Michael Hust; Stefan Dübel
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

10.  A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations.

Authors:  Federico Bertoglio; Viola Fühner; Maximilian Ruschig; Philip Alexander Heine; Leila Abassi; Thomas Klünemann; Ulfert Rand; Doris Meier; Nora Langreder; Stephan Steinke; Rico Ballmann; Kai-Thomas Schneider; Kristian Daniel Ralph Roth; Philipp Kuhn; Peggy Riese; Dorina Schäckermann; Janin Korn; Allan Koch; M Zeeshan Chaudhry; Kathrin Eschke; Yeonsu Kim; Susanne Zock-Emmenthal; Marlies Becker; Margitta Scholz; Gustavo Marçal Schmidt Garcia Moreira; Esther Veronika Wenzel; Giulio Russo; Hendrikus S P Garritsen; Sebastian Casu; Andreas Gerstner; Günter Roth; Julia Adler; Jakob Trimpert; Andreas Hermann; Thomas Schirrmann; Stefan Dübel; André Frenzel; Joop Van den Heuvel; Luka Čičin-Šain; Maren Schubert; Michael Hust
Journal:  Cell Rep       Date:  2021-07-07       Impact factor: 9.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.